Holen Sie sich die Stockscreener-App
8.72
1.25%
-0.11
Handel nachbörslich:
8.72
Schlusskurs vom Vortag:
$8.83
Offen:
$8.82
24-Stunden-Volumen:
92,044
Relative Volume:
0.86
Marktkapitalisierung:
$503.23M
Einnahmen:
$181.68M
Nettoeinkommen (Verlust:
$20.37M
KGV:
24.95
EPS:
0.3495
Netto-Cashflow:
$17.31M
1W Leistung:
-1.47%
1M Leistung:
+1.04%
6M Leistung:
+6.34%
1J Leistung:
+30.34%
1-Tages-Spanne:
$8.71
$8.83
1-Wochen-Bereich:
$8.65
$8.96
52-Wochen-Spanne:
$6.50
$9.35
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA vs TAK, TEVA, HLN, ZTS, VTRS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
8.72 | 503.23M | 181.68M | 20.37M | 17.31M | 0.3495 |
TAK
Takeda Pharmaceutical Co Adr
|
18.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.26 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.05 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
VTRS
Viatris Inc
|
17.83 | 20.48B | 14.57B | -296.50M | 1.64B | -0.259 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Eingeleitet | The Benchmark Company | Buy |
| 2024-07-03 | Eingeleitet | Stifel | Buy |
| 2018-02-02 | Eingeleitet | Chardan Capital Markets | Buy |
Kamada Ltd Aktie (KMDA) Neueste Nachrichten
Form 4 KAMADA LTD For: 26 September By Investing.com - Investing.com India
Big News: Lilach Payorski Adds $136K In Kamada Stock Options Io Portfolio - Benzinga
Amir London Makes Strategic Play: Invests $1.80M In Kamada Stock Options - Benzinga
Form 4 KAMADA LTD For: 25 September By Investing.com - Investing.com Canada
A special dividend changed the exercise prices on two stock-option awards for Kamada (KMDA)'s CEO. - Stock Titan
KAMADA LTD (NASDAQ: KMDA) Grants 86,500 Derivative Securities to Director Goldwasser Karnit - Kalkine Media
A dividend changed the exercise prices on options acquired by a Kamada (KMDA) director. - Stock Titan
Kamada (KMDA) HR VP receives two option awards that vest in four annual installments. - Stock Titan
Capitalizing On Growth Prospects, David Tsur Acquires A Substantial $59K In Kamada Stock Options - Benzinga
Capitalizing On Growth Prospects, Hanni Neheman Acquires A Substantial $115K In Kamada Stock Options - Benzinga
Nir Livneh Executes Major Move: Acquires $171K In Kamada Stock Options - Benzinga
Insider Activity Spotlight: Karnit Goldwasser Acquires $154K In Kamada Stock Options - Benzinga
Form 4 KAMADA LTD For: 24 September By Investing.com - Investing.com Canada
A special cash dividend led Kamada (KMDA) to adjust a VP’s stock option prices to $5.98 and $7.44. - Stock Titan
A cash dividend lowered the exercise prices of options awarded to Kamada (KMDA) counsel Nir Livneh. - Stock Titan
Kamada (KMDA) VP’s option prices were adjusted for a special dividend: $5.98 and $7.44 a share. - Stock Titan
Options for Kamada (KMDA) director Leon Recanati vest 25% a year and expire after 10 years. - Stock Titan
A special dividend changed the exercise prices on Kamada (KMDA) CFO's stock options. - Stock Titan
Dividend-linked option reset for Kamada (KMDA) VP - Stock Titan
KAMADA LTD (NASDAQ: KMDA) Director Tsur David Granted 37,500 Derivative Securities on August 27, 2026 - Kalkine Media
Kamada (KMDA) director reports 46,000 options at $6.10–$7.38 - Stock Titan
Kamada (NASDAQ: KMDA) grants director 46,000 options; exercise prices adjusted for dividend - Stock Titan
Stock options for Kamada (NASDAQ: KMDA) VP priced at $5.98 and $7.44 - Stock Titan
David Tsur Executes Major Move: Acquires $61K In Kamada Stock Options - Benzinga
Form 4 KAMADA LTD For: 23 September By Investing.com - Investing.com India
Special-dividend-adjusted options for Kamada (KMDA) VP - Stock Titan
Three option awards for a Kamada (KMDA) director carry prices from $5.99 to $7.41 per share. - Stock Titan
Kamada Ltd. stock holds gains after recent move in healthcare sector - AD HOC NEWS
Kamada Stock Price Forecast. Should You Buy KMDA? - StockInvest.us
StoneX reiterates Kamada stock buy rating on rabies treatment supply By Investing.com - Investing.com India
Kamada Ltd. (KMDA) Stock Analysis: A Healthcare Gem With 55.71% Potential Upside - DirectorsTalk Interviews
Kamada VP of Quality Yael Brenner Executes Five Stock Option Grants on September 14, 2026 - Kalkine Media
Kamada Ltd Director David Tsur Sells 22,827 Shares in September 2026 Transaction - Kalkine Media
Kamada (NASDAQ: KMDA) VP exercises options, uses 7,395 shares to cover costs - Stock Titan
Net option move leaves Kamada (KMDA) legal chief 3,459 shares - stocktitan.net
Kamada Maintains 'Sufficient' KedRAB Supply, Production Capacity Amid Increasing Rabies Exposures in US - marketscreener.com
Kamada Assures Adequate KedRAB Supply as U.S. Rabies Exposures Surge - TipRanks
Rising U.S. rabies exposures test supply; Kamada (NASDAQ: KMDA) says it is ready - Stock Titan
About 1.4 million people seek rabies care yearly. Kamada says supply is ready. - Stock Titan
CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand - Yahoo Finance
KAMADA LTD SEC Filing (Sep 16, 2026) - Stock Titan
KAMADA (NASDAQ: KMDA) Director Tsur David Sells 177,173 Shares in Three Deals Between Sept 7-9, 2026 - Kalkine Media
Co-Founder & Independent Deputy Chairman of the Board David Tsur Sold A Bunch Of Shares In Kamada - simplywall.st
Kamada director David Tsur disposes of USD 1.47 million in ordinary shares - Bitget
Director David Tsur Sells 177,173 Shares of Kamada Ltd (KMDA) - gurufocus.com
Kamada Ltd Director David Tsur Executes Three Consecutive Sales of Ordinary Shares - kalkinemedia.com
Kamada (KMDA) director sells shares over three days - Stock Titan
Kamada CEO to Present Growth Strategy at H.C. Wainwright Global Investment Conference - The Globe and Mail
Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
Kamada (KMDA) sets out a four‑pillar growth strategy - Stock Titan
Kamada's CEO is scheduled to speak in New York Sept. 15 - Stock Titan
Finanzdaten der Kamada Ltd-Aktie (KMDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kamada Ltd-Aktie (KMDA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Livneh Nir | VP, General Counsel |
Sep 14 '26 |
Option Exercise |
5.37 |
10,000 |
53,700 |
10,000 |
| Tsur David | Director |
Sep 14 '26 |
Sale |
8.18 |
22,827 |
186,725 |
407,929 |
| Tsur David | Director |
Sep 08 '26 |
Sale |
8.26 |
162,760 |
1,344,398 |
430,931 |
| Tsur David | Director |
Sep 07 '26 |
Sale |
8.28 |
14,238 |
117,891 |
593,691 |
| Tsur David | Director |
Sep 09 '26 |
Sale |
8.26 |
175 |
1,446 |
430,756 |
| Tsur David | Director |
Sep 02 '26 |
Option Exercise |
6.71 |
49,000 |
328,690 |
634,429 |
| Brenner Yael | VP Quality |
Sep 02 '26 |
Option Exercise |
5.94 |
3,036 |
18,034 |
9,302 |
| Brenner Yael | VP Quality |
Aug 26 '26 |
Option Exercise |
6.25 |
30,000 |
187,500 |
16,266 |
0.18%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):